Click to listen to the second episode of my interview with Dr. Joe Anderson of the Personalized Diagnostics Podcast. http://thepdxpodcast.cast.rocks/
Author: admin
I enjoyed discussing e-cigarettes, smoking, and FDA’s new vaping regulations with Bill Martinez!
I enjoyed discussing e-cigarettes, smoking, and FDA’s new vaping regulations with Bill Martinez on his nationally syndicated radio show on January 8th. Bill is now heard in over 300 markets! http://billmartinezlive.com/
I enjoyed discussing e-cigarettes, smoking, and the FDA’s new vaping regulations on the Bill Meyer show!
I enjoyed discussing e-cigarettes, smoking, and the FDA’s new vaping regulations on January 7 with Bill Meyer on his Bill Meyer Show, KMED AM-1440/FM 106.7, South Oregon. http://www.billmeyershow.com
Senators Susan Collins and Charles Grassley are working hard to lower drug costs for America’s seniors!
With all the “politics” going on in Washington, it is reassuring to know Senators Susan Collins and Finance Committee Chair Chuck Grassley are working hard to protect the Medicare Program and lower drug costs for our Nation’s senior citizens. Click below for my Op-Ed in the Lewiston Sun Journal to learn more. https://www.sunjournal.com/2020/01/16/roger-klein-prescription-drug-pricing-reduction-act-gains-backing/
Click below for my Op-Ed in The Hill today listing 3 actions the President can take to lower healthcare costs, improve efficiency and increase access!
Click below for my Op-Ed in The Hill today listing 3 actions the Trump Administration can take to lower healthcare costs and improve efficiency and consumer access in 2020. “Third, the president should resolve to finalize the administration’s “Strategy on Reducing Regulatory and Administrative Burden Relating to the Use of Health IT and EHRs” and…
I appreciated the opportunity to discuss new vaping regulations with Ray Dunaway and Joe D’Ambrosio this morning!
I appreciated the opportunity to discuss reported new vaping regulations with Ray Dunaway and Joe D’Ambrosio this morning on “Mornings with Ray Dunaway” – “WTIC NewsTalk 1080,” Hartford, CT. https://wtic.radio.com/shows/mornings-ray-dunaway
Quoted in Heartland Institute’s Health Care News about Google’s “Project Nightingale”!
I was quoted in Heartland Institute’s Health Care News about “Project Nightingale,” Google and Ascension Health’s data sharing partnership. One key question is whether the companies have obtained patients’ informed consent and institutional review board (IRB) approval for what appears to be research directed toward obtaining generalizable knowledge – rather than patient care or quality…
Click below for my interview about molecular diagnostics reimbursement with Joe Anderson!
Click to listen to the introduction to my interview about molecular diagnostics reimbursement with Joe Anderson on his Personalized Diagnostics Podcast! http://thepdxpodcast.cast.rocks/ “How exactly are molecular diagnostics tests reimbursed? Is our coding and reimbursement system up to the task? Roger D. Klein MD, JD, FCAP is a former HHS Advisor to FDA, CMS and CDC,…
Quoted yesterday in Dark Daily’s article “Canadian Scientists and Medical Researchers Urge Health Canada to Regulate Laboratory-developed Tests”
As in the U.S., advocates of enhanced regulation of laboratory developed procedures in the article below lack evidence justifying the imposition of an expensive, burdensome additional oversight framework that risks impairing patient access and stifling test innovation: However, in “FDA Looks to Clamp Down on Laboratory-Developed Tests and Put an End to ‘Wild West of…
Quoted in Heartland Institute’s Health Care News article: “Insurer Begins Covering Pharmacogenetic Testing Despite FDA Warning”
Click below for Heartland Institute’s Health Care News’ article about United Healthcare’s decision to cover some pharmacogenetics testing despite FDA’s safety communication that warns against use. Determining the effectiveness of drug therapy is an attractive prospect not just for doctors and patients, but third-party payers who bear the costs of prescription drugs. Klein says FDA’s…